# To Compare The Efficacy Of N -Acetylcysteine and Standard Therapy Versus Standard Therapy In The Prevention Of Ischemic Hepatitis And Survival Post Upper GI Bleed

> **NCT02015403** · NA · COMPLETED · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 220 (actual)

## Conditions studied

- Ischemic Hepatitis

## Interventions

- **DRUG:** Standard Care + NAC (N -ACETYLCYSTEINE)
- **DRUG:** Standard Care (in control arm)

## Key facts

- **NCT ID:** NCT02015403
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2019-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02015403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02015403, "To Compare The Efficacy Of N -Acetylcysteine and Standard Therapy Versus Standard Therapy In The Prevention Of Ischemic Hepatitis And Survival Post Upper GI Bleed". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02015403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*